Claire Najjuuko

Ms. Claire Najjuuko

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 August 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
CNClaire Najjuuko
Claire Najjuuko
ZXZiqi Xu
Ziqi Xu
SKSamuel Kizito
Samuel Kizito
CLChenyang Lu
Chenyang Lu
FSFred M. Ssewamala
Fred M. Ssewamala
Under-five mortality remains a global health issue, especially in sub-Saharan Africa, where preventable conditions largely drive the high mortality rates. Understanding the heterogeneity in utilization of reproductive, maternal, newborn, and child health services is crucial for reducing under-five mortality. Here we show that among 9307 under-five mortality cases across 31 sub-Saharan African countries (2014–2024), maternal and child health service utilization falls into three distinct patterns—lowest, medium, and highest. Socioeconomic status strongly predicts subgroup membership: higher maternal education, employment, urban residence, and wealth are associated with lower odds of being in the lowest utilization group. Inequality indices further reveal disparities by education, wealth, residence, and employment. Our findings show a strong link between socioeconomic status and maternal and child health services utilization. To address under-five mortality in sub-Saharan Africa, targeted strategies are needed to improve access and uptake of essential health services among socioeconomically disadvantaged groups.

8 March 2024 in JMIR Research Protocols
Verified
Journal Article
Open access
Proscovia NabunyaProscovia Nabunya
Proscovia Nabunya
PCPatricia Cavazos-Rehg
Patricia Cavazos-Rehg
JMJames Mugisha
James Mugisha
EKErin Kasson
Erin Kasson
ONOlive Imelda Namuyaba
Olive Imelda Namuyaba
FSFred. M. Ssewamala
Fred. M. Ssewamala
Background: People living with HIV often struggle with mental health comorbidities that lower their antiretroviral therapy (ART) adherence. There is growing evidence that depression treatment may improve ART adherence and result in improved HIV outcomes. Given that mental health services are severely underequipped in low-resource settings, including in Uganda, new solutions to increase access to mental health care and close the treatment gap are urgently needed. This protocol paper presents the Suubi-Mhealth study, which proposed to develop a mobile health (mHealth) intervention for use among Ugandan youths (14-17 years) with comorbid HIV and depression, taking into account their unique contextual, cultural, and developmental needs. Objective: The proposed study is guided by the following objectives: (1) to develop and iteratively refine an intervention protocol for Suubi-Mhealth based on formative work to understand the needs of youths living with HIV; (2) to explore the feasibility and acceptability of Suubi-Mhealth on a small scale to inform subsequent refinement; (3) to test the preliminary impact of Suubi-Mhealth versus a waitlist control group on youths’ outcomes, including depression and treatment adherence; and (4) to examine barriers and facilitators for integrating Suubi-Mhealth into health care settings. Methods: Youths will be eligible to participate in the study if they are (1) 14-17 years of age, (2) HIV-positive and aware of their status, (3) receiving care and ART from one of the participating clinics, and (4) living within a family. The study will be conducted in 2 phases. In phase 1, we will conduct focus group discussions with youths and health care providers, for feedback on the proposed intervention content and methods, and explore the feasibility and acceptability of the intervention. In phase II, we will pilot-test the preliminary impact of the intervention on reducing depression and improving ART adherence. Assessments will be conducted at baseline, 1-, 2-, and 6-months post intervention completion. Results: Participant recruitment for phase 1 is completed. Youths and health care providers participated in focus group discussions to share their feedback on the proposed Suubi-Mhealth intervention content, methods, design, and format. Transcription and translation of focus group discussions have been completed. The team is currently developing Suubi-Mhealth content based on participants’ feedback. Conclusions: This study will lay important groundwork for several initiatives at the intersection of digital therapeutics, HIV treatment, and mental health, especially among sub-Saharan African youths, as they transition through adolescence and into adult HIV care settings. Trial Registration: ClinicalTrials.gov NCT05965245; https://clinicaltrials.gov/study/NCT05965245 International Registered Report Identifier (IRRID): DERR1-10.2196/54635

24 February 2025 in AIDS
Verified
Journal Article
Closed access
CNClaire Najjuuko
Claire Najjuuko
RBRachel Brathwaite
Rachel Brathwaite
ZXZiqi Xu
Ziqi Xu
SKSamuel Kizito
Samuel Kizito
CLChenyang Lu
Chenyang Lu
FSFred. M. Ssewamala
Fred. M. Ssewamala
Objectives: Achieving optimal adherence to antiretroviral therapy (ART) and viral suppression is still insufficient for attaining the UNAIDS 95–95–95 target of 2030, especially among adolescents with HIV (AWHIV). This study sought to develop a model to predict poor adherence risk among AWHIV and identify associated risk factors. Design: We utilized machine learning to predict future ART adherence among AWHIV leveraging its ability to analyze complex, multidimensional data. Methods: We leveraged a dataset from a 6-year (2012–2018) longitudinal randomized control trial (RCT) with 635 AWHIV in Uganda. We evaluated six machine learning models and retained one with the highest area under receiver operating characteristic (AUROC), and area under precision-recall curve (AUPRC). We further identified principal factors associated with ART adherence based on the best model. Results: The random forest model outperformed others, with mean AUROC: 0.71 [BC 95% confidence interval (CI) (0.69–0.72)] and AUPRC: 0.55 (BC 95% CI 0.53–0.58). The principal risk factors of poor adherence were poor adherence history; poverty; biological relationship to caregiver; self-concept; savings confidence; duration on ART; frequency discussing sensitive topics with caregivers; household size; economic group assignment; and school enrollment. Conclusion: Our findings support potential use of machine learning methods and sociobehavioral data for predicting poor ART adherence risk among AWHIV. The predictive tool can help identify AWHIV at the highest risk of treatment failure, and enable early targeted interventions. However, the tool is still preliminary and its accuracy could be improved by incorporating HIV phenotypic and clinical data. Clinical Trial Number: ClinicalTrials.gov ID:NCT01790373

14 May 2026 in Clinical Infectious Diseases
Verified
Journal Article
Open access
JNJoshua Nordman
Joshua Nordman
CNClaire Najjuuko
Claire Najjuuko
NJNicholas Jeschke
Nicholas Jeschke
RSRachael E Snyders
Rachael E Snyders
MGMaria Cristina Vazquez Guillamet
Maria Cristina Vazquez Guillamet
ASAbby Sung
Abby Sung
Background: Catheter-associated urinary tract infection (CAUTI) surveillance is critical for patient safety. Many healthcare systems use electronic algorithms to flag candidate infection events but still require manual chart review to confirm CAUTI cases. We evaluated the use of a large language model (LLM) to enhance CAUTI surveillance. Methods: We analyzed 919 potential CAUTI cases flagged by the electronic surveillance algorithm at Barnes-Jewish Hospital from 2021 to 2024. These cases were previously classified as 291 CAUTIs and 628 non-CAUTIs by trained infection preventionists (IPs). Several approaches for applying the National Healthcare Safety Network (NHSN) CAUTI definition after extracting clinical data from the electronic medical record (EMR) were compared. Results: Most patients were female (61.6%) with a median age 68 years (IQR 58, 77). Combining rule-based logic with Clinical Entity Augmented Retrieval (CLEAR) input into an LLM achieved the highest sensitivity (90.0%) and specificity (93.5%). Adjustment of false negatives and false positives after expert adjudication showed sensitivity of 93.6% and specificity of 98.6%. Chart review of false negatives revealed that disagreement with the gold standard mainly occurred due to missing symptom information in clinical documentation provided to the model. Conclusions: Augmenting the existing algorithmic approach with LLM capabilities significantly enhances CAUTI surveillance and may improve efficiency by reducing the amount of time IPs spend performing manual chart review. Further improvements could be made by optimizing the clinical information presented to the model.

21 March 2026 in Global Social Welfare
Verified
Journal Article
Open access
PDF file
VSVicent Ssentumbwe
Vicent Ssentumbwe
FMFrancis Matovu
Francis Matovu
PNPhionah Namatovu
Phionah Namatovu
CNClaire Najjuuko
Claire Najjuuko
SKSamuel Kizito
Samuel Kizito
FSFred. M Ssewamala
Fred. M Ssewamala
Background: Adolescents living with HIV (ALWHIV) face a high prevalence of depression. In Uganda, limited access to mental health services exacerbates depression, necessitating innovative solutions for early detection and intervention. Machine learning (ML) provides a promising approach for identifying adolescents at risk of depression to facilitate early intervention. This study aims to use machine learning to predict depression among ALWHIV in Uganda. Methods: This study analyzed cross-sectional data from 833 ALWHIV aged 10–17 years in Southern Uganda. Depression was assessed using the Children’s Depression Inventory (CDI) –short version. Seven ML models, including Random Forest, Logistic Regression, Gradient Boosting, decision tree, XGBoost, Least Absolute Shrinkage and Selection Operator (LASSO), and Support Vector Machine, were evaluated using stratified 10-fold cross-validation. Model performance metrics included Area under receiver operating characteristic curve (AUROC), Area under precision-recall curve (AUPRC), accuracy, sensitivity, specificity, and F1-score. SHapley Additive exPlanations (SHAP) analysis was used to interpret feature importance. Results: The median age was 13 years, and the majority of the participants were females (55.5%). The prevalence of depression was 30.97%. The Random Forest model achieved the highest performance (AUROC = 0.79, AUPRC = 0.66). Key predictors of depression included hopelessness, HIV stigma, shame, self-esteem, teacher support, and caregiver support. SHAP analysis highlighted psychosocial challenges as primary predictors of depression, emphasizing the need for psychosocial-based interventions. Conclusion: Our study results demonstrated good performance of ML in predicting depression among ALWHIV. However, we acknowledge that the absence of external validation limits the generalizability of these findings. Future research should seek to validate these models in independent cohorts of ALWHIV to confirm their robustness and applicability across different settings.

16 November 2023 in JMIR Preprints
Verified
Preprint
Open access
Proscovia NabunyaProscovia Nabunya
Proscovia Nabunya
PCPatricia Cavazos-Rehg
Patricia Cavazos-Rehg
JMJames Mugisha
James Mugisha
EKErin Kasson
Erin Kasson
ONOlive Imelda Namuyaba
Olive Imelda Namuyaba
FSFred. M. Ssewamala
Fred. M. Ssewamala
BACKGROUND People living with HIV often struggle with mental health comorbidities that lower their antiretroviral therapy (ART) adherence. There is growing evidence that depression treatment may improve ART adherence and result in improved HIV outcomes. Given that mental health services are severely underequipped in low-resource settings, including in Uganda, new solutions to increase access to mental health care and close the treatment gap are urgently needed. This protocol paper presents the Suubi-Mhealth study, which proposed to develop a mobile health (mHealth) intervention for use among Ugandan youths (14-17 years) with comorbid HIV and depression, taking into account their unique contextual, cultural, and developmental needs. OBJECTIVE The proposed study is guided by the following objectives: (1) to develop and iteratively refine an intervention protocol for Suubi-Mhealth based on formative work to understand the needs of youths living with HIV; (2) to explore the feasibility and acceptability of Suubi-Mhealth on a small scale to inform subsequent refinement; (3) to test the preliminary impact of Suubi-Mhealth versus a waitlist control group on youths’ outcomes, including depression and treatment adherence; and (4) to examine barriers and facilitators for integrating Suubi-Mhealth into health care settings. METHODS Youths will be eligible to participate in the study if they are (1) 14-17 years of age, (2) HIV-positive and aware of their status, (3) receiving care and ART from one of the participating clinics, and (4) living within a family. The study will be conducted in 2 phases. In phase 1, we will conduct focus group discussions with youths and health care providers, for feedback on the proposed intervention content and methods, and explore the feasibility and acceptability of the intervention. In phase II, we will pilot-test the preliminary impact of the intervention on reducing depression and improving ART adherence. Assessments will be conducted at baseline, 1-, 2-, and 6-months post intervention completion. RESULTS Participant recruitment for phase 1 is completed. Youths and health care providers participated in focus group discussions to share their feedback on the proposed Suubi-Mhealth intervention content, methods, design, and format. Transcription and translation of focus group discussions have been completed. The team is currently developing Suubi-Mhealth content based on participants’ feedback. CONCLUSIONS This study will lay important groundwork for several initiatives at the intersection of digital therapeutics, HIV treatment, and mental health, especially among sub-Saharan African youths, as they transition through adolescence and into adult HIV care settings. CLINICALTRIAL ClinicalTrials.gov NCT05965245; https://clinicaltrials.gov/study/NCT05965245 INTERNATIONAL REGISTERED REPORT DERR1-10.2196/54635